For: | Meng LY, Yang CT, Bao JF, Huang JS. Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients. World J Gastroenterol 2024; 30(26): 3261-3263 [PMID: 39086637 DOI: 10.3748/wjg.v30.i26.3261] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i26/3261.htm |
Number | Citing Articles |
1 |
Ruirong Tan, Hua Hua, Siyuan Zhou, Zhimin Yang, Changming Yang, Guo Huang, Jin Zeng, Junning Zhao. Current landscape of innovative drug development and regulatory support in China. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02267-y
|
2 |
Chuang Jiang, Zhi-Hong Zhang, Jia-Xin Li. Current status of drug therapy for chronic hepatitis B. World Journal of Gastroenterology 2025; 31(2): 99443 doi: 10.3748/wjg.v31.i2.99443
|